483 Response Novartis Pharmaceuticals Dec 2018

Kassa Ayalew FDA, Cheryl Grandinetti FDA, Peter Lenahan FDA$119.00 - Available Now

FDA investigators audited the Novartis Pharmaceuticals - East Hanover, NJ, United States facility and issued inspectional observation (via FDA 483) on 14 Dec 2018.

Product details

  • Category:
  • Inspection end: 14 Dec 2018
  • Location: East Hanover, United States
  • FEI: 2210396
Add To Cart